Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Dioxybenzone | hsa00190 | Oxidative phosphorylation | 1.94E-02 | 3 | Q16718, P36542, O14521 | NDUFA5, ATP5C1, SDHD | More | | Dioxybenzone | hsa00220 | Arginine biosynthesis | 8.30E-04 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Dioxybenzone | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Dioxybenzone | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Dioxybenzone | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Dioxybenzone | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Dioxybenzone | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | | Dioxybenzone | hsa00565 | Ether lipid metabolism | 3.94E-02 | 1 | Q8N661 | TMEM86B | More | | Dioxybenzone | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.62E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Dioxybenzone | hsa00750 | Vitamin B6 metabolism | 3.56E-02 | 1 | O00764 | PDXK | More | | Dioxybenzone | hsa00830 | Retinol metabolism | 2.17E-03 | 4 | P00325, P00352, Q9BPW9, O75911 | ADH1B, ALDH1A1, DHRS9, DHRS3 | More | | Dioxybenzone | hsa00900 | Terpenoid backbone biosynthesis | 3.05E-02 | 1 | Q01581 | HMGCS1 | More | | Dioxybenzone | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Dioxybenzone | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Dioxybenzone | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Dioxybenzone | hsa00983 | Drug metabolism - other enzymes | 1.78E-03 | 5 | P04183, P32320, P05164, Q16772, P09211 | TK1, CDA, MPO, GSTA3, GSTP1 | More | | Dioxybenzone | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Dioxybenzone | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.56E-02 | 1 | P50213 | IDH3A | More | | Dioxybenzone | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 4.79E-03 | 3 | P49841, P42338, P04049 | GSK3B, PIK3CB, RAF1 | More | | Dioxybenzone | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Dioxybenzone | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Dioxybenzone | hsa03008 | Ribosome biogenesis in eukaryotes | 2.99E-02 | 2 | P78345, Q9BVP2 | RPP38, GNL3 | More | | Dioxybenzone | hsa03013 | RNA transport | 5.78E-05 | 15 | O14980, P52298, Q09161, O14893, Q7Z3B4, P35658, P47813, Q14152, O75822, P78345, Q14240, Q9BZI7, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, RPP38, EIF4A2, UPF3B, TACC3, FMR1, FXR1 | More | | Dioxybenzone | hsa03020 | RNA polymerase | 2.94E-07 | 4 | P24928, P62487, Q9GZM3, P52435 | POLR2A, POLR2G, POLR2J2, POLR2J | More | | Dioxybenzone | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | | Dioxybenzone | hsa03040 | Spliceosome | 4.48E-04 | 10 | Q14562, O43143, O60508, P17844, P51991, P61978, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, DDX5, HNRPA3, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8 | More | | Dioxybenzone | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04012 | ErbB signaling pathway | 4.79E-03 | 3 | P49841, P42338, P04049 | GSK3B, PIK3CB, RAF1 | More | | Dioxybenzone | hsa04014 | Ras signaling pathway | 3.82E-03 | 8 | P04049, Q9NRA1, Q13009, P0DP23, P62873, P63218, P50151, P19174 | RAF1, PDGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Dioxybenzone | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04022 | cGMP-PKG signaling pathway | 3.15E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04024 | cAMP signaling pathway | 2.49E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04060 | Cytokine-cytokine receptor interaction | 1.40E-05 | 17 | P14784, P27930, P14778, P08476, P26842, Q06643, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, O75509, P01375, P09341, P18510, P01730, Q93038 | IL2RB, IL1R2, IL1R1, INHBA, CD27, LTB, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNFRSF21, TNF, CXCL1, IL1RN, CD4, TNFRSF25 | More | | Dioxybenzone | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.57E-03 | 7 | P09341, P25024, P47992, Q9UBD3, Q13651, P14784, P01375 | CXCL1, CXCR1, XCL1, XCL2, IL10RA, IL2RB, TNF | More | | Dioxybenzone | hsa04062 | Chemokine signaling pathway | 1.00E-06 | 19 | P25024, P09341, P47992, Q9UBD3, P07948, P42338, P19174, P62873, P63218, P50151, P43250, P49407, Q08881, Q13009, P14598, P42224, P04049, P25963, P49841 | CXCR1, CXCL1, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ARRB1, ITK, TIAM1, NCF1, STAT1, RAF1, NFKBIA, GSK3B | More | | Dioxybenzone | hsa04064 | NF-kappa B signaling pathway | 1.79E-09 | 17 | P10415, Q13489, P25963, P51617, O00463, P14778, P01375, Q04759, Q9UDY8, Q13077, Q16548, P07948, P06239, Q13315, P24522, P09341, Q06643 | BCL2, BIRC3, NFKBIA, IRAK1, TRAF5, IL1R1, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LYN, LCK, ATM, GADD45A, CXCL1, LTB | More | | Dioxybenzone | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Dioxybenzone | hsa04071 | Sphingolipid signaling pathway | 1.65E-04 | 8 | P04049, P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | RAF1, PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Dioxybenzone | hsa04072 | Phospholipase D signaling pathway | 2.93E-03 | 4 | P04049, P42338, Q9UQC2, P25024 | RAF1, PIK3CB, GAB2, CXCR1 | More | | Dioxybenzone | hsa04080 | Neuroactive ligand-receptor interaction | 8.25E-05 | 11 | P08311, Q15722, P21453, Q9H228, O00398, Q01726, P41968, P21462, P21730, P14416, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, MC1R, MC3R, FPR1, C5AR1, DRD2, ADRB2 | More | | Dioxybenzone | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Dioxybenzone | hsa04114 | Oocyte meiosis | 1.33E-02 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Dioxybenzone | hsa04115 | p53 signaling pathway | 3.57E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Dioxybenzone | hsa04120 | Ubiquitin mediated proteolysis | 2.89E-02 | 2 | O95071, P0CG47 | UBR5, UBB | More | | Dioxybenzone | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Dioxybenzone | hsa04140 | Autophagy - animal | 2.95E-02 | 5 | P04049, P22694, Q14643, P10415, Q04759 | RAF1, PRKACB, ITPR1, BCL2, PRKCQ | More | | Dioxybenzone | hsa04141 | Protein processing in endoplasmic reticulum | 1.22E-04 | 11 | P18848, P30101, Q15437, P60604, Q99941, P11142, P07900, P08238, Q9NR31, Q9H173, Q9UNL2 | ATF4, PDIA3, SEC23B, UBE2G2, CREBL1, HSPA8, HSP90AA1, HSP90AB1, SAR1A, SIL1, SSR3 | More | | Dioxybenzone | hsa04145 | Phagosome | 7.52E-05 | 11 | P11215, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | ITGAM, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Dioxybenzone | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | | Dioxybenzone | hsa04150 | mTOR signaling pathway | 7.13E-04 | 6 | P42338, P04049, Q02750, Q9NQL2, P51812, P49841 | PIK3CB, RAF1, MAP2K1, RRAGD, RPS6KA3, GSK3B | More | | Dioxybenzone | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | | Dioxybenzone | hsa04210 | Apoptosis | 2.38E-04 | 12 | Q13315, P10415, Q13489, O76075, P25963, P01375, P24522, Q16548, Q13077, P43234, Q14643, P04049 | ATM, BCL2, BIRC3, DFFB, NFKBIA, TNF, GADD45A, BCL2A1, TRAF1, CTSO, ITPR1, RAF1 | More | | Dioxybenzone | hsa04211 | Longevity regulating pathway | 2.40E-03 | 5 | Q08828, P51828, Q99941, P18848, Q96RR4 | ADCY1, ADCY7, CREBL1, ATF4, CAMKK2 | More | | Dioxybenzone | hsa04218 | Cellular senescence | 2.49E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.46E-02 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Dioxybenzone | hsa04270 | Vascular smooth muscle contraction | 1.29E-04 | 5 | P0DP24, P04049, Q08828, P35579, P35318 | CALM2, RAF1, ADCY1, MYH9, ADM | More | | Dioxybenzone | hsa04340 | Hedgehog signaling pathway | 1.76E-03 | 5 | P49841, P22694, Q13635, P49407, P10415 | GSK3B, PRKACB, PTCH1, ARRB1, BCL2 | More | | Dioxybenzone | hsa04360 | Axon guidance | 3.26E-03 | 4 | P20827, P23528, P04049, Q06124 | EFNA1, CFL1, RAF1, PTPN11 | More | | Dioxybenzone | hsa04370 | VEGF signaling pathway | 1.79E-04 | 4 | P16298, Q05397, Q02750, P04049 | PPP3CB, PTK2, MAP2K1, RAF1 | More | | Dioxybenzone | hsa04371 | Apelin signaling pathway | 3.46E-04 | 8 | P62873, P63218, P50151, P04049, Q13370, Q14344, P84022, P0DP23 | GNB1, GNG5, GNG10, RAF1, PDE3B, GNA13, SMAD3, CALM1 | More | | Dioxybenzone | hsa04380 | Osteoclast differentiation | 3.38E-03 | 4 | Q9UQC2, P42338, P14778, Q8N149 | GAB2, PIK3CB, IL1R1, LILRA2 | More | | Dioxybenzone | hsa04390 | Hippo signaling pathway | 2.30E-02 | 3 | P63261, P04628, O43623 | ACTG1, WNT1, SNAI2 | More | | Dioxybenzone | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04540 | Gap junction | 2.22E-03 | 5 | Q13509, P68371, Q71U36, P04049, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, RAF1, PDGFC | More | | Dioxybenzone | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.53E-03 | 4 | P04628, P40189, P04049, P14653 | WNT1, IL6ST, RAF1, HOXB1 | More | | Dioxybenzone | hsa04612 | Antigen processing and presentation | 8.19E-05 | 8 | P13765, P48382, P01730, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, CD4, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Dioxybenzone | hsa04613 | Neutrophil extracellular trap formation | 2.63E-05 | 14 | P17252, P04049, O60603, P05164, P08246, Q9UM07, Q6FI13, P14598, Q15080, P20160, P08311, P49913, P21730, P21462 | PRKCA, RAF1, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF1, NCF4, AZU1, CTSG, CAMP, C5AR1, FPR1 | More | | Dioxybenzone | hsa04621 | NOD-like receptor signaling pathway | 3.10E-03 | 11 | Q14643, P25963, Q13489, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P49913, P12838 | ITPR1, NFKBIA, BIRC3, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CAMP, DEFA4 | More | | Dioxybenzone | hsa04623 | Cytosolic DNA-sensing pathway | 2.59E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Dioxybenzone | hsa04625 | C-type lectin receptor signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04630 | JAK-STAT signaling pathway | 3.67E-03 | 4 | P48551, P40189, Q06124, P04049 | IFNAR2, IL6ST, PTPN11, RAF1 | More | | Dioxybenzone | hsa04640 | Hematopoietic cell lineage | 1.05E-05 | 12 | P13612, P14778, P27930, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375 | ITGA4, IL1R1, IL1R2, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF | More | | Dioxybenzone | hsa04650 | Natural killer cell mediated cytotoxicity | 2.77E-08 | 13 | P16298, P50591, P01375, P06239, O60880, P20963, Q02750, P04049, Q13241, P26718, O14931, P26717, P26715 | PPP3CB, TNFSF10, TNF, LCK, SH2D1A, CD247, MAP2K1, RAF1, KLRD1, KLRK1, NCR3, KLRC2, KLRC1 | More | | Dioxybenzone | hsa04657 | IL-17 signaling pathway | 2.29E-02 | 5 | O00463, P09341, P14780, P80188, P01375 | TRAF5, CXCL1, MMP9, LCN2, TNF | More | | Dioxybenzone | hsa04658 | Th1 and Th2 cell differentiation | 2.83E-11 | 12 | Q04759, P07766, P20963, P09693, P01730, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P08311 | CTSG | Cathepsin G | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.81 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.742 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.85 |
| Dioxybenzone | hsa04659 | Th17 cell differentiation | 6.90E-10 | 17 | P25963, Q04759, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P84022, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, SMAD3, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P06239 | LCK | Tyrosine-protein kinase Lck | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.727 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | P06239 | LCK | Tyrosine-protein kinase Lck | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.777 | P08311 | CTSG | Cathepsin G | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.863 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.795 | P06239 | LCK | Tyrosine-protein kinase Lck | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.782 | P08311 | CTSG | Cathepsin G | Q9HBE5 | IL21R | Interleukin-21 receptor | -0.763 | P06239 | LCK | Tyrosine-protein kinase Lck | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.866 | P08311 | CTSG | Cathepsin G | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.795 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.735 | P06239 | LCK | Tyrosine-protein kinase Lck | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.77 | P08311 | CTSG | Cathepsin G | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.85 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 |
| Dioxybenzone | hsa04660 | T cell receptor signaling pathway | 7.91E-09 | 15 | P01375, P25963, Q9UDY8, Q04759, P10747, O95267, Q08881, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, P04049 | TNF, NFKBIA, MALT1, PRKCQ, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, RAF1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08246 | ELA2 | Neutrophil elastase | P01375 | TNF | Tumor necrosis factor | 0.751 | P08311 | CTSG | Cathepsin G | P01375 | TNF | Tumor necrosis factor | 0.733 | P08246 | ELA2 | Neutrophil elastase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.701 | P08246 | ELA2 | Neutrophil elastase | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.896 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.723 | P06239 | LCK | Tyrosine-protein kinase Lck | Q04759 | PRKCQ | Protein kinase C theta type | 0.779 | P08246 | ELA2 | Neutrophil elastase | Q04759 | PRKCQ | Protein kinase C theta type | -0.748 | P08311 | CTSG | Cathepsin G | Q04759 | PRKCQ | Protein kinase C theta type | -0.913 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q04759 | PRKCQ | Protein kinase C theta type | 0.776 | P08246 | ELA2 | Neutrophil elastase | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.854 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | 0.794 | P08246 | ELA2 | Neutrophil elastase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.724 | P08311 | CTSG | Cathepsin G | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.705 | P06239 | LCK | Tyrosine-protein kinase Lck | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.774 | P08246 | ELA2 | Neutrophil elastase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.782 | P08311 | CTSG | Cathepsin G | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.746 | P06239 | LCK | Tyrosine-protein kinase Lck | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.928 | P06239 | LCK | Tyrosine-protein kinase Lck | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.927 | P08311 | CTSG | Cathepsin G | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.888 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.74 | P06239 | LCK | Tyrosine-protein kinase Lck | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.752 | P08311 | CTSG | Cathepsin G | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.706 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.744 | P06239 | LCK | Tyrosine-protein kinase Lck | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.746 | P06239 | LCK | Tyrosine-protein kinase Lck | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.841 | P08311 | CTSG | Cathepsin G | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.826 | P42330 | AKR1C3 | Aldo-keto reductase family 1 member C3 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.92 | P06239 | LCK | Tyrosine-protein kinase Lck | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.714 | P06239 | LCK | Tyrosine-protein kinase Lck | P06239 | LCK | Tyrosine-protein kinase Lck | 1 | P08311 | CTSG | Cathepsin G | P06239 | LCK | Tyrosine-protein kinase Lck | -0.816 | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | P04049 | RAF1 | RAF proto-oncogene serine/threonine-protein kinase | 1 |
| Dioxybenzone | hsa04662 | B cell receptor signaling pathway | 2.64E-04 | 4 | P49841, P42338, Q8N149, P04049 | GSK3B, PIK3CB, LILRA2, RAF1 | More | | Dioxybenzone | hsa04664 | Fc epsilon RI signaling pathway | 2.82E-06 | 8 | P04141, P42338, Q9UQC2, P07948, P19174, P04049, P09917, P20292 | CSF2, PIK3CB, GAB2, LYN, PLCG1, RAF1, ALOX5, ALOX5AP | More | | Dioxybenzone | hsa04666 | Fc gamma R-mediated phagocytosis | 9.11E-03 | 3 | P42338, P04049, Q9UQC2 | PIK3CB, RAF1, GAB2 | More | | Dioxybenzone | hsa04668 | TNF signaling pathway | 2.59E-02 | 7 | P01375, O00463, Q13489, P25963, P20749, Q13077, P14780 | TNF, TRAF5, BIRC3, NFKBIA, BCL3, TRAF1, MMP9 | More | | Dioxybenzone | hsa04670 | Leukocyte transendothelial migration | 4.20E-02 | 7 | P14780, Q96A32, P17252, P14598, Q15080, Q08881, P42681 | MMP9, MYLPF, PRKCA, NCF1, NCF4, ITK, TXK | More | | Dioxybenzone | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Dioxybenzone | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Dioxybenzone | hsa04720 | Long-term potentiation | 2.17E-03 | 4 | P16298, P51812, Q02750, P04049 | PPP3CB, RPS6KA3, MAP2K1, RAF1 | More | | Dioxybenzone | hsa04722 | Neurotrophin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04724 | Glutamatergic synapse | 1.57E-02 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Dioxybenzone | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Dioxybenzone | hsa04726 | Serotonergic synapse | 5.74E-03 | 5 | P62873, P63218, P50151, P09917, P04049 | GNB1, GNG5, GNG10, ALOX5, RAF1 | More | | Dioxybenzone | hsa04727 | GABAergic synapse | 4.18E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Dioxybenzone | hsa04728 | Dopaminergic synapse | 2.30E-03 | 6 | P14416, P49841, Q99941, P18848, Q13557, P49407 | DRD2, GSK3B, CREBL1, ATF4, CAMK2D, ARRB1 | More | | Dioxybenzone | hsa04730 | Long-term depression | 1.95E-02 | 3 | Q14344, P04049, P07948 | GNA13, RAF1, LYN | More | | Dioxybenzone | hsa04744 | Phototransduction | 9.21E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Dioxybenzone | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.88E-02 | 2 | P14778, P42338 | IL1R1, PIK3CB | More | | Dioxybenzone | hsa04810 | Regulation of actin cytoskeleton | 3.81E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04910 | Insulin signaling pathway | 1.49E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Dioxybenzone | hsa04912 | GnRH signaling pathway | 3.36E-03 | 4 | P51828, P18848, Q13557, P04049 | ADCY7, ATF4, CAMK2D, RAF1 | More | | Dioxybenzone | hsa04914 | Progesterone-mediated oocyte maturation | 5.89E-03 | 4 | Q17RY0, P51812, Q02750, P04049 | CPEB4, RPS6KA3, MAP2K1, RAF1 | More | | Dioxybenzone | hsa04915 | Estrogen signaling pathway | 4.99E-04 | 6 | P04049, Q99941, P18848, P51828, P07900, P11142 | RAF1, CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8 | More | | Dioxybenzone | hsa04916 | Melanogenesis | 2.96E-03 | 3 | P49841, Q01726, P04049 | GSK3B, MC1R, RAF1 | More | | Dioxybenzone | hsa04917 | Prolactin signaling pathway | 1.31E-03 | 3 | P42338, P04049, P49841 | PIK3CB, RAF1, GSK3B | More | | Dioxybenzone | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Dioxybenzone | hsa04919 | Thyroid hormone signaling pathway | 1.82E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04920 | Adipocytokine signaling pathway | 4.49E-02 | 4 | P25963, P33121, Q04759, P01375 | NFKBIA, ACSL1, PRKCQ, TNF | More | | Dioxybenzone | hsa04921 | Oxytocin signaling pathway | 2.32E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Dioxybenzone | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Dioxybenzone | hsa04925 | Aldosterone synthesis and secretion | 1.15E-04 | 6 | Q99941, P18848, Q08828, P51828, P0DP24, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CAMK2D | More | | Dioxybenzone | hsa04926 | Relaxin signaling pathway | 7.01E-03 | 4 | Q99941, P18848, P51828, P04049 | CREBL1, ATF4, ADCY7, RAF1 | More | | Dioxybenzone | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Dioxybenzone | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.06E-03 | 8 | Q14643, P51828, P22694, P23771, P04049, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, RAF1, CREBL1, ATF4, BCL2 | More | | Dioxybenzone | hsa04929 | GnRH secretion | 2.72E-04 | 3 | P42338, P49407, P04049 | PIK3CB, ARRB1, RAF1 | More | | Dioxybenzone | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Dioxybenzone | hsa04935 | Growth hormone synthesis, secretion and action | 5.33E-03 | 4 | P51828, P04049, Q99941, P18848 | ADCY7, RAF1, CREBL1, ATF4 | More | | Dioxybenzone | hsa04960 | Aldosterone-regulated sodium reabsorption | 8.43E-03 | 2 | P42338, P48048 | PIK3CB, KCNJ1 | More | | Dioxybenzone | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Dioxybenzone | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Dioxybenzone | hsa04970 | Salivary secretion | 4.49E-02 | 4 | P22694, Q14643, P17252, P49913 | PRKACB, ITPR1, PRKCA, CAMP | More | | Dioxybenzone | hsa04971 | Gastric acid secretion | 3.46E-02 | 2 | P48048, P78508 | KCNJ1, KCNJ10 | More | | Dioxybenzone | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | | Dioxybenzone | hsa05012 | Parkinson disease | 1.77E-02 | 6 | P60604, P19174, P0DP23, Q71U36, Q13509, P68371 | UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | | Dioxybenzone | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Dioxybenzone | hsa05016 | Huntington disease | 2.46E-05 | 3 | Q9GZM3, P52435, Q9NYC9 | POLR2J2, POLR2J, DNAH9 | More | | Dioxybenzone | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Dioxybenzone | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Dioxybenzone | hsa05032 | Morphine addiction | 2.18E-02 | 4 | P62873, P63218, P50151, Q13370 | GNB1, GNG5, GNG10, PDE3B | More | | Dioxybenzone | hsa05034 | Alcoholism | 3.36E-03 | 3 | Q96RR4, P04049, P84243 | CAMKK2, RAF1, H3F3A | More | | Dioxybenzone | hsa05100 | Bacterial invasion of epithelial cells | 4.50E-02 | 1 | Q92529 | SHC3 | More | | Dioxybenzone | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.08E-02 | 4 | P25963, Q13488, P19174, P07948 | NFKBIA, TCIRG1, PLCG1, LYN | More | | Dioxybenzone | hsa05130 | Pathogenic Escherichia coli infection | 3.19E-02 | 6 | Q71U36, P16333, Q13509, P68371, Q14344, P25963 | TUBA1A, NCK1, TUBB3, TUBB2C, GNA13, NFKBIA | More | | Dioxybenzone | hsa05131 | Shigellosis | 3.34E-02 | 11 | P01375, P25963, O00463, Q04759, Q9UDY8, Q9H1Y0, Q14643, Q12778, Q13315, P10415, Q96A32 | TNF, NFKBIA, TRAF5, PRKCQ, MALT1, ATG5, ITPR1, FOXO1, ATM, BCL2, MYLPF | More | | Dioxybenzone | hsa05132 | Salmonella infection | 1.96E-03 | 17 | P51617, P25963, P01375, P08238, P04049, Q9UJU2, Q13489, P10415, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754 | IRAK1, NFKBIA, TNF, HSP90AB1, RAF1, LEF1, BIRC3, BCL2, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Dioxybenzone | hsa05134 | Legionellosis | 4.75E-02 | 3 | P25963, P11215, P11142 | NFKBIA, ITGAM, HSPA8 | More | | Dioxybenzone | hsa05140 | Leishmaniasis | 1.55E-03 | 9 | P14598, P11215, P42224, P13765, O60603, P25963, P01375, P51617, Q15080 | NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, IRAK1, NCF4 | More | | Dioxybenzone | hsa05145 | Toxoplasmosis | 7.78E-03 | 9 | P51617, P25963, P01375, P10415, Q13489, P28068, P13765, Q16787, O60603 | IRAK1, NFKBIA, TNF, BCL2, BIRC3, HLA-DMB, HLA-DOB, LAMA3, TLR2 | More | | Dioxybenzone | hsa05146 | Amoebiasis | 1.45E-05 | 9 | P09341, P14778, P27930, P01375, P42338, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, PIK3CB, ARG1, PRKACB, ACTN1, CTSG | More | | Dioxybenzone | hsa05150 | Staphylococcus aureus infection | 4.02E-03 | 6 | P21462, O75015, Q14532, P59665, P59666, P12838 | FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4 | More | | Dioxybenzone | hsa05152 | Tuberculosis | 1.41E-02 | 10 | P04049, Q13488, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | RAF1, TCIRG1, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Dioxybenzone | hsa05160 | Hepatitis C | 1.99E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05161 | Hepatitis B | 5.07E-04 | 12 | P17252, P04049, P14780, Q99941, P18848, P25963, P01375, P10415, P27348, P51617, O60603, Q14765 | PRKCA, RAF1, MMP9, CREBL1, ATF4, NFKBIA, TNF, BCL2, YWHAQ, IRAK1, TLR2, STAT4 | More | | Dioxybenzone | hsa05163 | Human cytomegalovirus infection | 3.19E-05 | 17 | P42338, P04049, P25963, P62873, P63218, P50151, P0DP23, P0DP24, Q14344, Q08828, P23458, P49841, P14778, P61073, Q99941, P30101, P01568 | PIK3CB, RAF1, NFKBIA, GNB1, GNG5, GNG10, CALM1, CALM2, GNA13, ADCY1, JAK1, GSK3B, IL1R1, CXCR4, CREBL1, PDIA3, IFNA21 | More | | Dioxybenzone | hsa05164 | Influenza A | 3.65E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05165 | Human papillomavirus infection | 2.01E-02 | 3 | Q16787, Q02930, Q13315 | LAMA3, CREB5, ATM | More | | Dioxybenzone | hsa05166 | Human T-cell leukemia virus 1 infection | 2.91E-02 | 3 | Q02930, P28068, Q13315 | CREB5, HLA-DMB, ATM | More | | Dioxybenzone | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.32E-06 | 15 | P01568, P42224, P25963, P62873, P62879, P63218, P50151, P19174, P16298, P04049, Q02750, P07948, P04141, P0DP23, P0CG47 | IFNA21, STAT1, NFKBIA, GNB1, GNB2, GNG5, GNG10, PLCG1, PPP3CB, RAF1, MAP2K1, LYN, CSF2, CALM1, UBB | More | | Dioxybenzone | hsa05168 | Herpes simplex virus 1 infection | 3.79E-02 | 9 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, ZNF211, ZNF189 | More | | Dioxybenzone | hsa05169 | Epstein-Barr virus infection | 4.84E-03 | 10 | P13765, P01106, Q13547, O00463, P07948, Q13761, P24522, P07766, P09693, P20963 | HLA-DOB, MYC, HDAC1, TRAF5, LYN, RUNX3, GADD45A, CD3E, CD3G, CD247 | More | | Dioxybenzone | hsa05170 | Human immunodeficiency virus 1 infection | 3.00E-07 | 26 | P04049, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, P01375, Q05397, P17252, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, O95067, P19174, P10415, Q13619, Q93034, Q9Y6Q5, P20333 | RAF1, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, TNF, PTK2, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, CCNB2, PLCG1, BCL2, CUL4A, CUL5, AP1M2, TNFRSF1B | More | | Dioxybenzone | hsa05200 | Pathways in cancer | 1.99E-03 | 15 | P08238, P42224, P25963, P19174, P43246, P84022, P20585, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, MSH3, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Dioxybenzone | hsa05202 | Transcriptional misregulation in cancer | 4.58E-07 | 17 | Q12778, Q15532, Q13315, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Dioxybenzone | hsa05203 | Viral carcinogenesis | 1.75E-03 | 7 | Q12933, Q99941, P18848, P42229, P27348, Q15283, P61978 | TRAF2, CREBL1, ATF4, STAT5A, YWHAQ, RASA2, HNRPK | More | | Dioxybenzone | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Dioxybenzone | hsa05205 | Proteoglycans in cancer | 3.48E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05206 | MicroRNAs in cancer | 3.15E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05210 | Colorectal cancer | 1.66E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05211 | Renal cell carcinoma | 1.16E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05212 | Pancreatic cancer | 9.52E-03 | 4 | P04049, P42224, P84022, O75293 | RAF1, STAT1, SMAD3, GADD45B | More | | Dioxybenzone | hsa05213 | Endometrial cancer | 2.80E-04 | 5 | O15169, P49841, P42338, Q02750, P04049 | AXIN1, GSK3B, PIK3CB, MAP2K1, RAF1 | More | | Dioxybenzone | hsa05214 | Glioma | 7.45E-03 | 4 | P0DP23, P04049, P19174, O75293 | CALM1, RAF1, PLCG1, GADD45B | More | | Dioxybenzone | hsa05215 | Prostate cancer | 6.80E-04 | 4 | P49841, P42338, P04049, P27930 | GSK3B, PIK3CB, RAF1, IL1R2 | More | | Dioxybenzone | hsa05218 | Melanoma | 6.63E-03 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05219 | Bladder cancer | 4.98E-03 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05220 | Chronic myeloid leukemia | 9.95E-03 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05221 | Acute myeloid leukemia | 8.29E-03 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05222 | Small cell lung cancer | 2.79E-02 | 6 | Q13489, P10415, P25963, Q13077, O00463, P24522 | BIRC3, BCL2, NFKBIA, TRAF1, TRAF5, GADD45A | More | | Dioxybenzone | hsa05223 | Non-small cell lung cancer | 6.63E-03 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05224 | Breast cancer | 5.52E-03 | 3 | P04049, P42338, P49841 | RAF1, PIK3CB, GSK3B | More | | Dioxybenzone | hsa05225 | Hepatocellular carcinoma | 2.35E-03 | 4 | P04049, P42338, P49841, P51531 | RAF1, PIK3CB, GSK3B, SMARCA2 | More | | Dioxybenzone | hsa05226 | Gastric cancer | 3.26E-03 | 3 | P04049, Q02750, O15169 | RAF1, MAP2K1, AXIN1 | More | | Dioxybenzone | hsa05230 | Central carbon metabolism in cancer | 9.95E-03 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05231 | Choline metabolism in cancer | 1.33E-02 | 1 | P04049 | RAF1 | More | | Dioxybenzone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.31E-05 | 10 | O95267, P07766, P20963, P09693, P06239, P04049, O60603, P10747, Q04759, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, RAF1, TLR2, CD28, PRKCQ, CD4 | More | | Dioxybenzone | hsa05310 | Asthma | 3.13E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Dioxybenzone | hsa05321 | Inflammatory bowel disease | 3.29E-07 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Dioxybenzone | hsa05322 | Systemic lupus erythematosus | 4.90E-03 | 9 | P08246, P08311, P01375, P10747, P13765, Q6FI13, Q16778, P12814, P05455 | ELA2, CTSG, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST2H2BE, ACTN1, SSB | More | | Dioxybenzone | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Dioxybenzone | hsa05332 | Graft-versus-host disease | 1.46E-06 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Dioxybenzone | hsa05340 | Primary immunodeficiency | 2.19E-02 | 4 | P01730, P01732, P07766, P06239 | CD4, CD8A, CD3E, LCK | More | | Dioxybenzone | hsa05416 | Viral myocarditis | 2.30E-02 | 2 | P10747, P63261 | CD28, ACTG1 | More | | Dioxybenzone | hsa05418 | Fluid shear stress and atherosclerosis | 2.02E-02 | 3 | P42338, P14778, P27930 | PIK3CB, IL1R1, IL1R2 | More | | |